α adrenergic agents
    9.
    发明授权
    α adrenergic agents 失效
    α肾上腺素能药

    公开(公告)号:US06919357B2

    公开(公告)日:2005-07-19

    申请号:US10215547

    申请日:2002-08-09

    摘要: Aspects of the present invention are directed towards compounds of Formula I for the treatment of human erectile disorders including erectile dysfunction in men. wherein: R1 is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, cyclohexyl, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; R2 is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; R3 is a group of the formula R4 is hydrogen or C1-C6 alkyl; R5 is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; and R6 is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, carboxy, amino, C1-C6 alkylamino, or (C1-C6 alkyl)2amino; or pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明的方面涉及用于治疗男性勃起功能障碍的人类勃起障碍的式I化合物。 其中:R 1是氢,卤素,羟基,硝基,氰基,苯基,三氟甲基,C 1 -C 6烷基,C C 1 -C 6烷氧基,羧基,氨基,环己基,C 1 -C 6烷基氨基或(C 1个C 6 -C 6烷基)亚氨基; R 2是氢,卤素,羟基,硝基,氰基,三氟甲基,C 1 -C 6烷基,C 1〜 或C 1 -C 6烷氧基,羧基,氨基,C 1 -C 6烷基氨基或(C 1 -C 6) -C 6 -C 6烷基)亚氨基; R 3是式R 4的基团是氢或C 1 -C 6烷基; R 3是氢或C 1 -C 6烷基; R 5是氢,卤素,羟基,硝基,氰基,苯基,三氟甲基,C 1 -C 6烷基,C 1 C 1 -C 6烷氧基,羧基,氨基,C 1 -C 6烷基氨基或(C 1〜 C 1 -C 6烷基)亚氨基; 和R 6是氢,卤素,羟基,硝基,氰基,三氟甲基,C 1 -C 6烷基,C 1〜 C 1 -C 6烷氧基,羧基,氨基,C 1 -C 6烷基氨基或(C 1 -C 12) C 6 -C 6烷基)亚氨基; 或其药学上可接受的盐。